10x Genomics NASDAQ TXG
$27.58 -0.22 -0.80%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 19 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.27B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

2.92B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.41
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

118.57M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-50.71 %
Upcoming events 10x Genomics All events
No upcoming events scheduled

Stock chart 10x Genomics

Stock analysis 10x Genomics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-12.82 -0.41
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
4.41 1.10
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-14.42 0.24
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.72 0.34
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-34.42 -21.27

Price change 10x Genomics per year

125.84$ 208.99$
Min Max

Summary analysis 10x Genomics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure 10x Genomics

Revenue and net income 10x Genomics

All parameters
Stock news 10x Genomics All news

10X Genomics Wins Permanent Injunction in NanoString Patent Litigation -- Update

10X Genomics Wins Permanent Injunction in NanoString Patent Litigation -- Update

10X Genomics Wins Permanent Injunction in NanoString Patent Litigation

10X Genomics Wins Permanent Injunction in NanoString Patent Litigation

Premarket Movers: Wolfspeed, XP, 10x Genomics

10X Genomics' Stock Got Crushed. Here's Why.

10x Genomics stock suffering record drop toward record low after revenue warnings prompts downgrade

Premarket Movers: 10x Genomics, Pinterest, National Retail Prperties

Premarket Movers: 10x Genomics, Pinterest, National Retail Prperties

Premarket Movers: 10x Genomics, Pinterest, National Retail Prperties

10x Genomics Sees Lower 2Q Revenue, Shares Fall 15%

10x Genomics Sees Lower 2Q Revenue, Shares Fall 15%

10x Genomics stock falls as revenue forecast disappoints

Premarket Movers: DocuSign, Rivian Automotive, 10x Genomics

10x Genomics Shares Lower After 4Q Miss, Guidance Below Views

10x Genomics Shares Lower After 4Q Miss, Guidance Below Views

10x Genomics Shares Dive on Weaker-Than-Expected Guidance

10x Genomics Shares Dive on Weaker-Than-Expected Guidance

Premarket Movers: DoorDash, 10x Genomics, Applovin

10x Genomics downgraded to neutral from buy at BofA Securities

About company 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Address:
6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588
Company name: 10x Genomics
Issuer ticker: TXG
ISIN: US88025U1097
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-09-12
Sector: Healthcare
Industry: Biotechnology
Site: https://www.10xgenomics.com

On which stock exchange are 10x Genomics (TXG) stocks traded?

10x Genomics (TXG) stocks are traded on NASDAQ.

What is the ticker of 10x Genomics stocks (TXG)?

The stock ticker of 10x Genomics’s stocks or in other words, the code is TXG. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does 10x Genomics (TXG) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, 10x Genomics (TXG) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are 10x Genomics (TXG) stocks traded?

10x Genomics (TXG) stocks are traded on the NASDAQ exchange in dollars.

What is the price of 10x Genomics (TXG) stocks today?

The current price of 10x Genomics stocks on 24.04.2024 is 27.58 dollars. per share.

What is the dynamics of 10x Genomics (TXG) stocks from the beginning of the year?

10x Genomics (TXG) quotes have increased by -49.21% from the beginning of the year up to 27.58 dollars. per 1 stocks.

How much did 10x Genomics (TXG) stocks increase in апреле 2024?

This month 10x Genomics (TXG) quotes have increased by -25.56% to 27.58 dollars. per share.

How much are 10x Genomics (TXG) stocks worth?

Today, on October, 24.04.2024 10x Genomics’s (TXG) stocks cost 27.58 dollars..

What is the market capitalization of 10x Genomics (TXG)?

Capitalization is the market value of 10x Genomics (TXG) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 24.04.2024, the market capitalization of 10x Genomics (TXG) is estimated at about 3270042668 dollars.